D. E. Shaw & Co., Inc. Optimize Rx Corp Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Optimize Rx Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 263,655 shares of OPRX stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

263,655

Holding current value

$1.28 Million

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.2 - $11.23 $321,688 - $501,745	-44,679 Reduced 14.49%	263,655 $2.04 Million
Q2 2024 Aug 14, 2024	SELL	$8.8 - $13.17 $356,910 - $534,148	-40,558 Reduced 11.62%	308,334 $3.08 Million
Q1 2024 May 15, 2024	SELL	$11.47 - $16.17 $1.3 Million - $1.84 Million	-113,615 Reduced 24.57%	348,892 $4.24 Million
Q4 2023 Feb 14, 2024	SELL	$7.06 - $14.49 $973,475 - $2 Million	-137,886 Reduced 22.97%	462,507 $6.62 Million
Q3 2023 Nov 14, 2023	BUY	$7.43 - $14.96 $478,596 - $963,633	64,414 Added 12.02%	600,393 $4.67 Million
Q2 2023 Aug 14, 2023	BUY	$11.63 - $15.63 $753,007 - $1.01 Million	64,747 Added 13.74%	535,979 $7.66 Million
Q1 2023 May 15, 2023	BUY	$12.54 - $19.38 $3.59 Million - $5.55 Million	286,250 Added 154.74%	471,232 $6.89 Million
Q4 2022 Feb 14, 2023	BUY	$13.77 - $22.04 $1.38 Million - $2.22 Million	100,553 Added 119.1%	184,982 $3.11 Million
Q3 2022 Nov 14, 2022	BUY	$13.74 - $30.13 $1.16 Million - $2.54 Million	84,429 New	84,429 $1.25 Million
Q2 2021 Aug 16, 2021	SELL	$42.76 - $63.33 $377,912 - $559,710	-8,838 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$33.36 - $62.2 $346,443 - $645,947	-10,385 Reduced 54.02%	8,838 $431,000
Q4 2020 Feb 16, 2021	BUY	$19.04 - $33.1 $366,005 - $636,281	19,223 New	19,223 $599,000

Others Institutions Holding OPRX

# of Institutions

Shares Held

12.2M

Call Options Held

800

Put Options Held

18.1K

View Full List

About OptimizeRx Corp

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $87.6M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

More about OPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account